ARIS vs. ZVRA
ARIS (Aris Water Solutions, Inc.) and ZVRA (Zevra Therapeutics Inc.) are both stocks. ARIS operates in Utilities - Regulated Water (Utilities), while ZVRA operates in Biotechnology (Healthcare). Over the past 3 years, ARIS returned 76.24%/yr vs 24.74%/yr for ZVRA. Their 0.10 correlation means their historical movements had little consistent relationship.
Performance
ARIS vs. ZVRA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARIS achieves a -17.68% return, which is significantly lower than ZVRA's 6.14% return.
ARIS
- 1D
- -6.25%
- 1M
- -8.62%
- 6M
- -22.05%
- YTD
- -17.68%
- 1Y
- 92.23%
- 3Y*
- 76.24%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 28.29%
ZVRA
- 1D
- -1.35%
- 1M
- -31.14%
- 6M
- 5.67%
- YTD
- 6.14%
- 1Y
- -14.40%
- 3Y*
- 24.74%
- 5Y*
- -1.18%
- 10Y*
- -17.62%
- ALL TIME*
- -23.23%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $19.88M | $21.50M | $22.93M | |
| $18.33M | $18.68M | $21.76M |
ARIS vs. ZVRA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
ARIS Aris Water Solutions, Inc. | -17.68% | 363.71% | 6.54% | 31.93% | -39.60% | 1.33% |
ZVRA Zevra Therapeutics Inc. | 6.14% | 7.43% | 27.33% | 42.70% | -47.30% | -10.57% |
Correlation
The correlation between ARIS and ZVRA is 0.11, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.11 |
Correlation (3Y) Balances recent behavior with more history. | 0.11 |
Correlation (All Time) Calculated using the full available price history since Oct 22, 2021 | 0.10 |
Fundamentals
ARIS:
$2.76B
ZVRA:
$562.18M
ARIS:
$1.37
ZVRA:
$2.15
ARIS:
9.75
ZVRA:
4.43
ARIS:
2.18
ZVRA:
4.50
ARIS:
1.59
ZVRA:
2.78
ARIS:
$1.26B
ZVRA:
$122.29M
ARIS:
$677.96M
ZVRA:
$104.94M
ARIS:
$584.28M
ZVRA:
$149.15M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARIS vs. ZVRA — Risk / Return Rank
ARIS
ZVRA
ARIS vs. ZVRA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aris Water Solutions, Inc. (ARIS) and Zevra Therapeutics Inc. (ZVRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ARIS | ZVRA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.02 | ||
| Sortino ratioReturn per unit of downside risk | +2.02 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 1.02 | +0.27 |
| Calmar ratioReturn relative to maximum drawdown | 2.91 | -0.36 | +3.27 |
| Martin ratioReturn relative to average drawdown | 7.16 | -0.65 | +7.81 |
Loading charts...
Drawdowns
ARIS vs. ZVRA - Drawdown Comparison
The maximum ARIS drawdown since its inception was -57.98%, smaller than the maximum ZVRA drawdown of -99.27%. Use the drawdown chart below to compare losses from any high point for ARIS and ZVRA.
Loading charts...
Drawdown Indicators
| ARIS | ZVRA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -57.98% | -99.27% | +41.29% |
Max Drawdown (1Y)Largest decline over 1 year | -38.29% | -40.40% | +2.11% |
Max Drawdown (3Y)Largest decline over 3 years | -38.29% | -43.47% | +5.18% |
Max Drawdown (5Y)Largest decline over 5 years | — | -60.97% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -97.85% | — |
Current DrawdownCurrent decline from peak | -38.29% | -97.48% | +59.19% |
Average DrawdownAverage peak-to-trough decline | -22.90% | -86.53% | +63.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.58% | 22.22% | -7.64% |
Volatility
ARIS vs. ZVRA - Volatility Comparison
The current volatility for Aris Water Solutions, Inc. (ARIS) is 19.50%, while Zevra Therapeutics Inc. (ZVRA) has a volatility of 29.44%. This indicates that ARIS experiences smaller price fluctuations and is considered to be less risky than ZVRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARIS | ZVRA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.50% | 29.44% | -9.94% |
Volatility (6M)Calculated over the trailing 6-month period | 47.43% | 49.17% | -1.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 62.04% | 65.35% | -3.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 53.44% | 61.11% | -7.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 53.44% | 81.05% | -27.61% |
Dividends
ARIS vs. ZVRA - Dividend Comparison
Neither ARIS nor ZVRA has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
ARIS Aris Water Solutions, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 3.84% | 0.85% |
ZVRA Zevra Therapeutics Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
ARIS vs. ZVRA - Financials Comparison
This section allows you to compare key financial metrics between Aris Water Solutions, Inc. and Zevra Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ARIS and ZVRA have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ZVRA has higher volatility (29.44%) compared to ARIS (19.50%). In terms of maximum drawdown, ARIS dropped -57.98% vs ZVRA's -99.27%.
ARIS currently has the higher Sharpe Ratio (1.80 vs -0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARIS and ZVRA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer